Indirect comparisons of new oral anticoagulant drugs for efficacy and safety when used for stroke prevention in atrial fibrillation

This study sought to perform an indirect comparison analysis of dabigatran etexilate (2 doses), rivaroxaban, and apixaban for their relative efficacy and safety against each other. Data for warfarin compared against the new oral anticoagulants (OACs) in large phase III clinical trials of stroke prev...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Journal of the American College of Cardiology Ročník 60; číslo 8; s. 738
Hlavní autoři:	Lip, Gregory Y H, Larsen, Torben Bjerregaard, Skjøth, Flemming, Rasmussen, Lars Hvilsted
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	United States 21.08.2012
Témata:	Administration, Oral Aged Anticoagulants - administration & dosage Anticoagulants - adverse effects Anticoagulants - therapeutic use Atrial Fibrillation - complications Benzimidazoles - administration & dosage Benzimidazoles - adverse effects Benzimidazoles - therapeutic use Clinical Trials, Phase III as Topic Dabigatran Female Hemorrhage - chemically induced Humans Male Middle Aged Morpholines - administration & dosage Morpholines - adverse effects Morpholines - therapeutic use Odds Ratio Pyrazoles - administration & dosage Pyrazoles - adverse effects Pyrazoles - therapeutic use Pyridines - administration & dosage Pyridines - adverse effects Pyridines - therapeutic use Pyridones - administration & dosage Pyridones - adverse effects Pyridones - therapeutic use Rivaroxaban Stroke - etiology Stroke - prevention & control Thiophenes - administration & dosage Thiophenes - adverse effects Thiophenes - therapeutic use Treatment Outcome
ISSN:	1558-3597, 1558-3597
On-line přístup:	Zjistit podrobnosti o přístupu
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!